News

Genomtec has received notification from the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) ...

Company has has received a notice of allowance from the Japan Patent Office (JPO) granting the Company patent protection for the Genomtec®ID ...

Company has filed a patent application for a proprietary primer set, diagnostic method and reaction mixture composition for genetic diagnosis of ...

Genomtec S.A. has expressed its intention to seek a transfer of the Company’s listing from the alternative stock exchange of NewConnect to ...

Genomtec S.A. has published a report for the second quarter of 2021 containing financial results and a summary of the most important activities ...

Genomtec SA has been certified in accordance to ISO 13485 standard for its quality management system compliance via audits carried out by TÜV ...